Case number 2018-2023
GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 9, 2021 | 5 | ORDER filed. Teva Pharmaceuticals USA, Inc.'s petition [739781-2] is granted to the extent that the 10/02/2020 judgment is vacated, the 10/02/2020 opinions are withdrawn, and the panel witll rehear these appeals on the merits. Telephonic oral argument is set for 02/23/2021 at 10:00 a.m. Oral argument shall be limited as noted in the order. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [754738] [18-1976, 18-2023] [MJL] [Entered: 02/09/2021 10:41 AM] (2) |
| Oct 2, 2020 | 3 | OPINION filed for the court by Prost, Chief Judge; Newman, Circuit Judge and Moore, Circuit Judge. Dissenting opinion filed by Chief Judge Prost. Precedential Opinion. [726095] [18-1976, 18-2023]. Withdrawn pursuant to the court's order. See Doc. No. [5]. [MJL] [Entered: 10/02/2020 11:01 AM] (53) |
| Oct 2, 2020 | 4 | JUDGMENT. VACATED AND REMANDED. Terminated on the merits after oral argument. COSTS: Each side bears its own costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [726098] [18-1976, 18-2023]. Vacated pursuant to the court's order. See Doc. No. [5]. [MJL] [Entered: 10/02/2020 11:11 AM] (1) |
| May 31, 2018 | 1 | Appeal docketed. Received: 05/25/2018. [525729] [CMP] [Entered: 05/31/2018 10:01 AM] (60) |
| May 31, 2018 | 2 | Note to file: The following cases are associated: 18-1976 Lead with 18-2023 Cross-Appeal. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [525731] [18-1976, 18-2023] [CMP] [Entered: 05/31/2018 10:07 AM] (0) |
